October 6, 2014, Updated October 5, 2014
Dozens of prescription medicine bottles in a jumble. (Shutterstock.com)
Dozens of prescription medicine bottles in a jumble. (Shutterstock.com)

Prescription errors result in morbidity, mortality and wasteful healthcare costs, harming hundreds of thousands of people annually in the United States alone. Israel’s MedAware, a developer of big data analytics for the medical prescription market, has developed an innovative software-based solution that combines the power of big data analytics and machine learning to save lives and reduce medical costs and combat the prevalence of those errors.

“Three years ago I came across a tragic case of a nine-year-old Israeli boy who died because his primary-care physician accidentally prescribed the wrong drug,” said MedAware Co-founder and CEO Gidi Stein. “The ease with which a little boy died because of a mistaken click of a button was horrifying to me as a physician and as a parent. We have founded MedAware in order to try and prevent such cases.”

MedAware recently completed a $1 million Series A financing round led by equity crowdfunding platform OurCrowd. Together with GE Ventures, it is the two firms’ first co-investment since entering into a strategic partnership in November 2013, and GE’s first software investment in Israel’s growing healthcare industry. The money raised will be used to drive initial sales to healthcare providers, insurance companies and large pharmacy chains.

Current solutions such as electronic medical records and computerized physician order entry systems search for prescription errors based on manually predefined rules.  These systems miss errors that do not fall into their known rules, and also suffer from high false-alarm rates.  By contrast, MedAware uses big-data analytics and machine-learning algorithms to automatically learn how different clinical scenarios are managed by physicians in real world situations.

“MedAware embodies many of the same technologies we’ve seen accompany the emergence of the Industrial Internet,” said Jason Sibley, Director of Healthcare Ventures at GE Ventures. “From big data and analytics to machine learning and digital communications, the company aligns perfectly with GE’s vision for a healthcare industry driven by technology and built for improving lives, and we look forward to working together to help transform the medical prescription market.”

“We are excited about the potential for MedAware to solve the huge problem of prescription error via their impressive big data technology,” said Jon Medved, founder and CEO of OurCrowd. “The fact that our partner, General Electric, has joined together with us in this investment is further validation of this tremendous opportunity.”


Read more: